Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 1
2006 1
2007 3
2008 2
2009 5
2010 1
2011 1
2012 3
2013 1
2014 1
2015 1
2016 2
2018 4
2019 1
2020 1
2021 1
2022 1
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade.
Rocha P, Bach R, Masfarré L, Hernandez S, Navarro-Gorro N, Rossell A, Villanueva X, Giner M, Sanchéz I, Galindo M, Del Rey-Vergara R, Iñañez A, Sanchéz-Espiridion B, Lu W, Acedo-Terrades A, Berenguer-Molins P, Sánchez-Font A, Chalela R, Curull V, Taus Á, Hardy-Werbin M, Sausen M, Georgiadis A, White J, Jackson JB, Moliner L, Clavé S, Bellosillo B, Rovira A, Wistuba I, Soto LMS, Perera-Bel J, Arriola E. Rocha P, et al. Among authors: galindo m. Oncoimmunology. 2025 Dec;14(1):2469377. doi: 10.1080/2162402X.2025.2469377. Epub 2025 Feb 24. Oncoimmunology. 2025. PMID: 39991958 Free PMC article.
Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors.
Yélamos J, Galindo M, Navarro J, Albanell J, Rovira A, Rojo F, Oliver J. Yélamos J, et al. Among authors: galindo m. Oncoimmunology. 2015 Jul 1;5(1):e1065370. doi: 10.1080/2162402X.2015.1065370. eCollection 2016. Oncoimmunology. 2015. PMID: 26942084 Free PMC article. Review.
Enhancing immunotherapy through PD-L1 upregulation: the promising combination of anti-PD-L1 plus mTOR inhibitors.
Hernández-Prat A, Rodriguez-Vida A, Cardona L, Qin M, Arpí-Llucià O, Soria-Jiménez L, Menendez S, Quimis FG, Galindo M, Arriola E, Salido M, Juanpere-Rodero N, Rojo F, Muntasell A, Albanell J, Rovira A, Bellmunt J. Hernández-Prat A, et al. Among authors: galindo m. Mol Oncol. 2025 Jan;19(1):151-172. doi: 10.1002/1878-0261.13699. Epub 2024 Sep 11. Mol Oncol. 2025. PMID: 39258533 Free PMC article.
Mumps epidemiology in Cuba between 2004 and 2015.
Ribas MLA, Tejero Y, Valcarcel M, Galindo M, Cordero Y, Sausy A, Muller CP, Hübschen JM. Ribas MLA, et al. Among authors: galindo m. Arch Virol. 2018 Nov;163(11):3059-3064. doi: 10.1007/s00705-018-3946-z. Epub 2018 Aug 4. Arch Virol. 2018. PMID: 30078131
37 results